# AR Training Platform at Home

Study · id `cardio:ct-nct05627050` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05627050](<https://clinicaltrials.gov/study/NCT05627050>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05627050

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 600 participants.

## Technical summary

Registry record NCT05627050. Allocation not applicable; no masking; primary purpose treatment. Start 2021-01-13 (actual); primary completion 2024-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 600 participants (planned count; ClinicalTrials.gov record NCT05627050, source copy `cardio:ctgov-nct05627050-2022-11-25`, retrieved 2026-10-26)
- Started: 2021-01-13 (actual) (ClinicalTrials.gov record NCT05627050, source copy `cardio:ctgov-nct05627050-2022-11-25`, retrieved 2026-10-26)
- Primary completion: 2024-12 (anticipated) (ClinicalTrials.gov record NCT05627050, source copy `cardio:ctgov-nct05627050-2022-11-25`, retrieved 2026-10-26)
- Completion: 2024-12 (anticipated) (ClinicalTrials.gov record NCT05627050, source copy `cardio:ctgov-nct05627050-2022-11-25`, retrieved 2026-10-26)
- Countries: Hong Kong SAR China (ClinicalTrials.gov record NCT05627050, source copy `cardio:ctgov-nct05627050-2022-11-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05627050-2022-11-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: AR Training Platform at Home
- Condition: Stroke
- Condition: Chronic Disease
- Intervention (Device): An Online Augmented Reality (AR) Training Platform
- Lead sponsor: Chinese University of Hong Kong
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Chinese University of Hong Kong (`cardio:org-chinese-university-of-hong-kong`)

## Provenance

Content hash: ed254e2da78981fb20aa7762e1385bf2c7756f3e2236c9897f2d604b58b96728
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
